Home

Ammirevole Evento oasi lxr agonist clinical trial Maledetto urto Saturare

Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation  and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality |  Oncology
Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality | Oncology

Liver X receptors in lipid metabolism: opportunities for drug discovery |  Nature Reviews Drug Discovery
Liver X receptors in lipid metabolism: opportunities for drug discovery | Nature Reviews Drug Discovery

Targeting liver X receptors in cancer therapeutics | Nature Reviews Cancer
Targeting liver X receptors in cancer therapeutics | Nature Reviews Cancer

Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and  Lipoprotein Metabolism and Circulating Neutrophils - ScienceDirect
Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils - ScienceDirect

Frontiers | Liver X Receptors: Regulators of Cholesterol Metabolism,  Inflammation, Autoimmunity, and Cancer | Immunology
Frontiers | Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer | Immunology

Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia  and Atherosclerosis | Arteriosclerosis, Thrombosis, and Vascular Biology
Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis | Arteriosclerosis, Thrombosis, and Vascular Biology

Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear  Receptors PPARs, FXR, and LXR in NASH - Cellular and Molecular  Gastroenterology and Hepatology
Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH - Cellular and Molecular Gastroenterology and Hepatology

Cancers | Free Full-Text | Activation of LXR Receptors and Inhibition of  TRAP1 Causes Synthetic Lethality in Solid Tumors | HTML
Cancers | Free Full-Text | Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid Tumors | HTML

The effects of LXR agonist T0901317 and LXR antagonist GSK2033 on  morphogenesis and lipid properties in full thickness skin models -  ScienceDirect
The effects of LXR agonist T0901317 and LXR antagonist GSK2033 on morphogenesis and lipid properties in full thickness skin models - ScienceDirect

Liver x receptor alpha drives chemoresistance in response to side-chain  hydroxycholesterols in triple negative breast cancer | Oncogene
Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer | Oncogene

Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X  Receptors Agonist Promotes Atherosclerosis Regression - eBioMedicine
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression - eBioMedicine

Approved LXR agonists exert unspecific effects on pancreatic β-cell  function | SpringerLink
Approved LXR agonists exert unspecific effects on pancreatic β-cell function | SpringerLink

An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers  - ScienceDirect
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers - ScienceDirect

PDF) LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative  Diseases
PDF) LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases

LXR agonism promotes macroscopic change in the tumor microenvironment
LXR agonism promotes macroscopic change in the tumor microenvironment

Targeted Delivery of LXR Agonist Using a Site-Specific Antibody–Drug  Conjugate | Bioconjugate Chemistry
Targeted Delivery of LXR Agonist Using a Site-Specific Antibody–Drug Conjugate | Bioconjugate Chemistry

Approved LXR agonists exert unspecific effects on pancreatic β-cell  function | SpringerLink
Approved LXR agonists exert unspecific effects on pancreatic β-cell function | SpringerLink

Synthetic LXR agonists. | Download Scientific Diagram
Synthetic LXR agonists. | Download Scientific Diagram

Screening for liver X receptor modulators: Where are we and for what use? -  Buñay - 2021 - British Journal of Pharmacology - Wiley Online Library
Screening for liver X receptor modulators: Where are we and for what use? - Buñay - 2021 - British Journal of Pharmacology - Wiley Online Library

LXR agonist T0901317 down-regulates the hepatic gluconeogenesis pathway...  | Download Scientific Diagram
LXR agonist T0901317 down-regulates the hepatic gluconeogenesis pathway... | Download Scientific Diagram

Liver X receptors link lipid metabolism and inflammation - Schulman - 2017  - FEBS Letters - Wiley Online Library
Liver X receptors link lipid metabolism and inflammation - Schulman - 2017 - FEBS Letters - Wiley Online Library

Liver X receptors and fat cell metabolism | International Journal of Obesity
Liver X receptors and fat cell metabolism | International Journal of Obesity

Approved LXR agonists exert unspecific effects on pancreatic β-cell  function | SpringerLink
Approved LXR agonists exert unspecific effects on pancreatic β-cell function | SpringerLink

LXR Agonist-treated EOCs Decrease Atherosclerosis | Stem Cells Portal
LXR Agonist-treated EOCs Decrease Atherosclerosis | Stem Cells Portal

LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases  | SpringerLink
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases | SpringerLink

LXR-inverse agonism stimulates immune-mediated tumor destruction by  enhancing CD8 T-cell activity in triple negative breast cancer | Scientific  Reports
LXR-inverse agonism stimulates immune-mediated tumor destruction by enhancing CD8 T-cell activity in triple negative breast cancer | Scientific Reports

Liver X receptors in lipid metabolism: opportunities for drug discovery -  Document - Gale Academic OneFile
Liver X receptors in lipid metabolism: opportunities for drug discovery - Document - Gale Academic OneFile